Structural Biology and Molecular Modeling MarketStructural Biology and Molecular ModelingMarketwas valued at USD 6.1 Billion in 2021 and is projected to reach USD 18.1 Billion by 2028, growing at a Compound Annual Growth Rate (CAGR) of 17.1% during the forecast period of 2022-2028. Structural Biology and Molecular Modeling are powerful tools for studying the structure of three-dimensional biological macromolecules. Structural biology is the study of the cellular structure of biological macromolecules and energy, particularly proteins and nucleic acids, and how structural changes affect their function. Drug development companies are investing in modeling programs that will allow them to predict the development of newly developed drugs and cell components that will serve as bids. Therefore, these molecular modeling tools help to better understand the concept of life.
Growth in drug development processes and the growing need for modeling strategies to undertake possible studies to prevent learning failure is driving the Structural Biology and Molecular Modeling 10;Increasing the prevalence of chronic diseases and emerging Research and Development (R&D) studies to develop novel therapies with structural biology and modeling techniques encourage further growth of the 10;Advances in bioinformatics, molecular biology and modeling techniques are expected to stimulate market growth during forecasting. The growing demand for molecular modeling methods has been largely due to the allowed cost 10;This is because predictive software identifies potential adverse reactions and determines the effectiveness of the drug and its toxicity in preclinical stages, thus reducing the chances of drug failure in later stages. As a result, the factors mentioned above serve as key factors responsible for the growing demand for the market.
The rapid development of technology and innovation have strongly supported the global market over the past few years. Both of these factors have ensured sophisticated models that assist in accurately determining cellular interactions and function, which help identify the location of the problem and the next solution. A wide range of Structural Biology and Molecular Modeling techniques are expected to gain an astonishing range in the field of drug discovery. These methods will appear to be important in identifying non-existent fragments that limit the process of drug acquisition, thus resulting in higher success rates. The adoption of these methods in pharmacogenomics and pharmacogenetics is expected to prove beneficial to the overall market growth.
The Global Structural Biology and Molecular Modeling Market is divided based on tools such as Saas and modeling software, visual and analytics software, and other tools. Saas and modeling software further consists of types like homology modeling, threading, and molecular dynamics. On the basis of the application the market is divided into drug development, drug discovery, and more applications. On the basis of regional analysis, the Global Structural Biology and Molecular Modeling Market is categorized in North America, Europe, Asia Pacific, Latin America, and the Middle East and Africa.
North America is predicted to be holding the largest share in the Structural Biology and Molecular Modeling Market. The North America region is on a rise, due to various ongoing researches in biological sciences, considerable investments by various biotechnology companies, and the consistently increasing utilization of structural biology and molecular modeling techniques in the market. Owing to the ongoing research and outsourcing activities in the field of life science, Asia-Pacific also has lucrative opportunities for growth over the forecast period.
Major players in the Global Structural Biology and Molecular Modeling Market include Dassault Systèmes (France) , Agile Molecule , Acellera Ltd. (UK), ThermoFisher Scientific (US) , Agilent Technologies Inc (US) are the major companies operating in Structural Biology and Molecular Modeling Techniques Market..
Mar 27, 2024
